Parkinson's Trial NCT07710625
Check Turkish temperature sensitivity questionnaire
- Trial ID
- NCT07710625
- Official Title
- Cross-Cultural Adaptation and Psychometric Evaluation of the Turkish Version of the Temperature Sensitivity Scale in Individuals With Parkinson's Disease
- Goal
- Check Turkish temperature sensitivity questionnaire
- Status
- RECRUITING
- Sponsor
- Acibadem University
- Study Type
- OBSERVATIONAL
- Enrollment
- 100 participants
- Conditions
- Parkinson Disease, Temperature Sensivity
Summary For Families
The goal is to check whether the Turkish version of the Temperature Sensitivity Scale gives consistent and trustworthy results when used with people who have Parkinson's disease. To do that, researchers will have patients complete the Turkish questionnaire and will test whether the questions hold together, whether answers stay the same on repeat testing, and whether the scale measures sensitivity to temperature. They are looking for people aged 40 to 85 with early to mid-stage Parkinson's (Hoehn and Yahr stage 1 to 3), who can communicate and score 24 or higher on the Mini-Mental State Examination, and they will exclude people with major psychiatric illness, advanced dementia, uncontrolled chronic diseases like diabetes or high blood pressure, serious heart or lung disease, other conditions that would affect testing, or severe vision or hearing problems.
Locations
- Acibadem University, Istanbul, Turkey, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to check whether the Turkish version of the Temperature Sensitivity Scale gives consistent and trustworthy results when used with people who have Parkinson's disease. To do that, researchers will have patients complete the Turkish questionnaire and will test whether the questions hold together, whether answers stay the same on repeat testing, and whether the scale measures sensitivity to temperature. They are looking for people aged 40 to 85 with early to mid-stage Parkinson's (Hoehn and Yahr stage 1 to 3), who can communicate and score 24 or higher on the Mini-Mental State Examination, and they will exclude people with major psychiatric illness, advanced dementia, uncontrolled chronic diseases like diabetes or high blood pressure, serious heart or lung disease, other conditions that would affect testing, or severe vision or hearing problems.
- Who can participate?
- Participants must be between 40 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 7 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.